Evidence map›Paper›PMID 31766572›Full record

ArticleBiomolecules2019

Preparation and Evaluation of the ZnO NP-Ampicillin/Sulbactam Nanoantibiotic: Optimization of Formulation Variables Using RSM Coupled GA Method and Antibacterial Activities.

Nidhi Sharma, Vineeta Singh, Asheesh Kumar Pandey, Bhartendu Nath Mishra, Maria Kulsoom, Nandita Dasgupta, Saif Khan, Hesham A El-Enshasy, Shafiul Haque

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Antifungal activity ofFrontiers in microbiology · 2024
    Article
  3. Molecular Dynamic Analysis of Carbapenem-ResistantMolecules (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Biosynthesis of Zinc Oxide Nanoparticles fromMolecules (Basel, Switzerland) · 2021
    Article
  6. Review
  7. Effects of Zinc Oxide Nanoparticles Synthesized UsingFrontiers in cellular and infection microbiology · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Nidhi SharmaDepartment of Biotechnology, Institute of Engineering and Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Sitapur Road, Lucknow-226021, Uttar Pradesh, India.
Vineeta SinghDepartment of Biotechnology, Institute of Engineering and Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Sitapur Road, Lucknow-226021, Uttar Pradesh, India.
Asheesh Kumar PandeyDepartment of Biotechnology, Institute of Engineering and Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Sitapur Road, Lucknow-226021, Uttar Pradesh, India.
Bhartendu Nath MishraDepartment of Biotechnology, Institute of Engineering and Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Sitapur Road, Lucknow-226021, Uttar Pradesh, India.
Maria KulsoomDepartment of Biotechnology, Institute of Engineering and Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Sitapur Road, Lucknow-226021, Uttar Pradesh, India.
Nandita DasguptaDepartment of Biotechnology, Institute of Engineering and Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Sitapur Road, Lucknow-226021, Uttar Pradesh, India.
Saif KhanDepartment of Basic Sciences, College of Dental Sciences, University of Ha'il, Ha'il-2440, Saudi Arabia.
Hesham A El-EnshasyInstitute of Bioproduct Development (IBD), Universiti Teknologi Malaysia (UTM), Skudai, Johor Bahru 81310, Johor, Malaysia.
Shafiul HaqueResearch and Scientific Studies Unit, College of Nursing & Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.
Dr. A.P.J. Abdul Kalam Technical University · INCity of Scientific Research and Technological Applications · EGJazan University · SAUniversity of Ha'il · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) possessing antibacterial activity represent an effective way of overcoming bacterial resistance. In the present work, we report a novel formulation of a nanoantibiotic formed using Ampicillin/sulbactam (Ams) and a zinc oxide nanoparticle (ZnO NP). 'ZnO NP-Ams' nanoantibiotic formulation is optimized using response surface methodology coupled genetic algorithm approach. The optimized formulation of nanoantibiotic (ZnO NP: 49.9 μg/mL; Ams: 33.6 μg/mL; incubation time: 27 h) demonstrated 15% enhanced activity compared to the unoptimized formulation against

Indexed as

AlgorithmsAmpicillinAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialMicrobial Sensitivity TestsNanoparticlesReactive Oxygen SpeciesRegression AnalysisSulbactamZinc OxideAmpicillinAnti-Bacterial AgentsReactive Oxygen SpeciesSulbactamZinc Oxideampicillin/sulbactamgenetic algorithmKlebsiella pneumoniaeresponse surface methodologyZnO nanoparticle

Identifiers

PMID31766572
PMCPMC6995637
OpenAlexW2990679896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.